These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32411818)

  • 1. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
    Amgad M; Stovgaard ES; Balslev E; Thagaard J; Chen W; Dudgeon S; Sharma A; Kerner JK; Denkert C; Yuan Y; AbdulJabbar K; Wienert S; Savas P; Voorwerk L; Beck AH; Madabhushi A; Hartman J; Sebastian MM; Horlings HM; Hudeček J; Ciompi F; Moore DA; Singh R; Roblin E; Balancin ML; Mathieu MC; Lennerz JK; Kirtani P; Chen IC; Braybrooke JP; Pruneri G; Demaria S; Adams S; Schnitt SJ; Lakhani SR; Rojo F; Comerma L; Badve SS; Khojasteh M; Symmans WF; Sotiriou C; Gonzalez-Ericsson P; Pogue-Geile KL; Kim RS; Rimm DL; Viale G; Hewitt SM; Bartlett JMS; Penault-Llorca F; Goel S; Lien HC; Loibl S; Kos Z; Loi S; Hanna MG; Michiels S; Kok M; Nielsen TO; Lazar AJ; Bago-Horvath Z; Kooreman LFS; van der Laak JAWM; Saltz J; Gallas BD; Kurkure U; Barnes M; Salgado R; Cooper LAD;
    NPJ Breast Cancer; 2020; 6():16. PubMed ID: 32411818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
    Thagaard J; Broeckx G; Page DB; Jahangir CA; Verbandt S; Kos Z; Gupta R; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Akturk G; Almeida JS; Alvarado-Cabrero I; Amgad M; Azmoudeh-Ardalan F; Badve S; Baharun NB; Balslev E; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Bouchmaa N; Burgues O; Chardas A; Chon U Cheang M; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dahl AB; Dantas Portela FL; Deman F; Demaria S; Doré Hansen J; Dudgeon SN; Ebstrup T; Elghazawy M; Fernandez-Martín C; Fox SB; Gallagher WM; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hauberg S; Hewitt S; Hida AI; Horlings HM; Husain Z; Hytopoulos E; Irshad S; Janssen EA; Kahila M; Kataoka TR; Kawaguchi K; Kharidehal D; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Ly A; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rahman A; Rajpoot NM; Rapoport BL; Rau TT; Reis-Filho JS; Ribeiro JM; Rimm D; Roslind A; Vincent-Salomon A; Salto-Tellez M; Saltz J; Sayed S; Scott E; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Fineberg S; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; van Diest PJ; Verghese GE; Viale G; Vieth M; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Zin RM; Adams S; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Salgado R; Specht Stovgaard E
    J Pathol; 2023 Aug; 260(5):498-513. PubMed ID: 37608772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
    Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
    Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.
    Wein L; Savas P; Luen SJ; Virassamy B; Salgado R; Loi S
    Front Oncol; 2017; 7():156. PubMed ID: 28824872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer.
    Ochi T; Bianchini G; Ando M; Nozaki F; Kobayashi D; Criscitiello C; Curigliano G; Iwamoto T; Niikura N; Takei H; Yoshida A; Takei J; Suzuki K; Yamauchi H; Hayashi N
    Eur J Cancer; 2019 Sep; 118():41-48. PubMed ID: 31302586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.
    Van Bockstal MR; Cooks M; Nederlof I; Brinkhuis M; Dutman A; Koopmans M; Kooreman L; van der Vegt B; Verhoog L; Vreuls C; Westenend P; Kok M; van Diest PJ; Nauwelaers I; Laudus N; Denkert C; Rimm D; Siziopikou KP; Ely S; Zardavas D; Roberts M; Floris G; Hartman J; Acs B; Peeters D; Bartlett JMS; Dequeker E; Salgado R; Giudici F; Michiels S; Horlings H; van Deurzen CHM
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
    Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I
    Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
    Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
    Adv Anat Pathol; 2017 Sep; 24(5):235-251. PubMed ID: 28777142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I-III patients treated with standard therapy.
    Dieci MV; Tsvetkova V; Griguolo G; Miglietta F; Tasca G; Giorgi CA; Cumerlato E; Massa D; Lo Mele M; Orvieto E; Guarneri V; Conte P
    Eur J Cancer; 2020 Sep; 136():7-15. PubMed ID: 32622323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer.
    Kilmartin D; O'Loughlin M; Andreu X; Bagó-Horváth Z; Bianchi S; Chmielik E; Cserni G; Figueiredo P; Floris G; Foschini MP; Kovács A; Heikkilä P; Kulka J; Laenkholm AV; Liepniece-Karele I; Marchiò C; Provenzano E; Regitnig P; Reiner A; Ryška A; Sapino A; Specht Stovgaard E; Quinn C; Zolota V; Webber M; Roshan D; Glynn SA; Callagy G
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer.
    Sun P; He J; Chao X; Chen K; Xu Y; Huang Q; Yun J; Li M; Luo R; Kuang J; Wang H; Li H; Hui H; Xu S
    EBioMedicine; 2021 Aug; 70():103492. PubMed ID: 34280779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
    Schüler K; Bethmann D; Kaufhold S; Hartung C; Stückrath K; Lantzsch T; Uleer C; Hanf V; Peschel S; John J; Pöhler M; Buchmann J; Bürrig KF; Weigert E; Thomssen C; Kantelhardt EJ; Vetter M
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the guidelines and multiphoton imaging methods to improve the prognostic value of tumor-infiltrating lymphocytes in breast cancer.
    He J; Kang D; Xu M; Han Z; Guo W; Fu F; Qiu L; Zheng L; Xi G; Wang W; Ren W; Han X; Tu H; Li L; Wang C; Chen J
    J Biophotonics; 2023 Jul; 16(7):e202300060. PubMed ID: 36965036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial.
    Schiza A; Thurfjell V; Stenmark Tullberg A; Olofsson H; Lindberg A; Holmberg E; Bremer T; Micke P; Karlsson P; Wärnberg F; Strell C
    Eur J Cancer; 2022 Jun; 168():128-137. PubMed ID: 35236568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes in Patients with Advanced Breast Cancer Treated with Primary Systemic Therapy.
    Agarwal G; Vishvak Chanthar KMM; Katiyar S; Kumari N; Krishnani N; Sabaretnam M; Chand G; Mishra A; Lal P
    World J Surg; 2023 May; 47(5):1238-1246. PubMed ID: 36735048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.
    Pruneri G; Vingiani A; Bagnardi V; Rotmensz N; De Rose A; Palazzo A; Colleoni AM; Goldhirsch A; Viale G
    Ann Oncol; 2016 Feb; 27(2):249-56. PubMed ID: 26598540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
    Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
    Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics.
    Balkenhol MC; Ciompi F; Świderska-Chadaj Ż; van de Loo R; Intezar M; Otte-Höller I; Geijs D; Lotz J; Weiss N; de Bel T; Litjens G; Bult P; van der Laak JA
    Breast; 2021 Apr; 56():78-87. PubMed ID: 33640523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A panoptic segmentation dataset and deep-learning approach for explainable scoring of tumor-infiltrating lymphocytes.
    Liu S; Amgad M; More D; Rathore MA; Salgado R; Cooper LAD
    NPJ Breast Cancer; 2024 Jun; 10(1):52. PubMed ID: 38942745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.